Compare WSBC & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WSBC | VCYT |
|---|---|---|
| Founded | 1870 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | 1994 | 2013 |
| Metric | WSBC | VCYT |
|---|---|---|
| Price | $42.17 | $41.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $39.25 | ★ $44.00 |
| AVG Volume (30 Days) | 870.6K | ★ 1.3M |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 4.48% | N/A |
| EPS Growth | N/A | ★ 164.52 |
| EPS | ★ 1.79 | 0.66 |
| Revenue | N/A | N/A |
| Revenue This Year | $11.31 | $13.76 |
| Revenue Next Year | $7.06 | $12.35 |
| P/E Ratio | ★ $23.73 | $63.76 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.57 | $28.25 |
| 52 Week High | $43.02 | $60.91 |
| Indicator | WSBC | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 59.08 | 30.76 |
| Support Level | $38.53 | $40.83 |
| Resistance Level | N/A | $41.95 |
| Average True Range (ATR) | 0.62 | 2.55 |
| MACD | -0.10 | -0.87 |
| Stochastic Oscillator | 51.64 | 1.26 |
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).